Abstract
The aim of this study is to assess the efficacy and harms of the direct oral anticoagulants (DOACs) for patients with cancer-associated venous thromboembolism (VTE). The study was designed as a systematic literature review and meta-analysis of randomized clinical trials (RCTs) and observational studies in accordance with PRISMA guidelines. We will include publications with patients older …